Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1996-12-23
1999-02-23
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514 89, A61K 31675
Patent
active
058744207
ABSTRACT:
The present invention provides methods of altering vagal tone in a patient by administering a therapeutically effective amount of a mediator of P.sub.2x -purinoceptors located on vagal afferent nerve terminals to the patient. Diagnostic applications are also provided.
REFERENCES:
patent: 4673563 (1987-06-01), Berne et al.
patent: 5049372 (1991-09-01), Rapaport
patent: 5219841 (1993-06-01), Inaba et al.
patent: 5504090 (1996-04-01), Neely
Abbrachio et al., "Purinoceptors: Are There Families of P2X and P2Y Purinoceptors?", Pharmacol. Ther., 1994, 64, 445-475.
Amour et al., "Responsiveness of in situ canine nodose ganglion afferent neurones to epicardial mechanical or chemical stimuli", Cardiovasc. Res., 1994, 28, 1218-1225.
Belhassen et al., "A Comparative Study of the Electrophysiologic Effects of Striadyne, Adenosine Triphosphate and Adenosine in the Canine Heart", Cardiology, 1985, 72, 113-122.
Belhassen et al., "Electrophysiologic Effects of Adenosine Triphosphate and Adensine on the Mammalian Heart: Clinical and Experimental Aspects", J. Am. Coll. Cardiol., 1984, 4(2), 414-424.
Belhassen et al., "Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia", Circulation, 1988, 77(4), 795-805.
Belhassen et al., "Electrophysiologic effects of adenosine-5'-triphosphate on atrioventricular reentrant tachycardia", Circulation, 1983, 68(4), 827-833.
Benedini et al., "Value of purinic compounds in assessing sinus node dysfunction in man: A new diagnostic method", European Heart J., 1984, 5, 394-403.
Cardenas et al., "Efecto Del Acido Adenosintrifosforico Sobre Las Propiedades Fisiologicas Del Corazon", Arch. Inst. Cardiol. Mex., 1964, 34, 485-494 (English Summary provided).
Emmelin et al., "Systemic Effects of Adenosine Triphosphate", Br. J. Pharmacol. Chemotherap., 1948, 3, 273-284.
Fukunaga et al., "Intravenous ATP Attenuates Surgical Stress Responses and Reduces Inhalation Anesthetic Requirements in Humans", Anesthesiology, 1990, 73(A400).
Hugues et al., "Etude De L'Action Chronotrope De L'ATP Chez L'Homme", Coeur Med. Inter., 1980, 19, 227-234 (English Summary provided).
Hurt et al., "Electrophysiological-anatomic correlates of ATP-triggered vagal reflex in dogs. II. Vagal afferent traffic", Am. J. Physiol., 1994, 267, H1093-H1097.
Kobayashi et al., "Adenosine Triphosphate-Sensitive Ventricular Tachycardia in Man", Eur. J.C.P.E., 1994, 4(1), 11-19.
Li et al., "Effect of Adenosine or Adenosine Triphosphate on Antidromic Tachycardia", JACC, 1994, 24(3), 728-731.
Moro et al., "Dose related efficacy of adenosine triphosphate in spontaneous supraventricular tachyarrhythmias", Int. J. Cardiol., 1989, 25, 207-212.
Pelleg et al., "Electrophysiological Effects of Adenosine-Tri-Phosphate and Adenosine on the Canine Heart", Fed. Proc., 1983, 42, 731, No. 2571.
Pelleg et al., "Comparative Electrophysiologic Effects of Adenosine Triphosphate and Adenosine in the Canine Heart: Influence of Atropine, Propanolol, Vagotomy, Dipyridamole and Aminophylline", Am. J. Cardiol., 1985, 55, 571-576.
Pelleg et al., "Evidence for Vagal Involvement in the Electrophysiologic Actions of Exogenous Adenosine and Adenosine Triphosphate in the Canine Heart", J. Auton. Pharmac., 1985, 5, 207-212.
Pelleg et al., "Evidence Against Prostaglandin Mediation of the Differential Electrophysiologic Effects of ATP Versus Adenosine in the Canine Heart", J. Cardio. Pharm., 1986, 8, 534-538.
Pelleg et al., "Role of the vagus in modulation by Ca.sup.2+ of the depressant action of adenosine and adenosine 5'-triphosphate on the canine sinus node in vivo," J. Auton. Pharmac., 1987, 7, 127-134.
Pelleg et al., "Electrophysiologic-anatomic correlates of ATP-triggered vagal reflex in dogs", Am. J. Physiol., 1993, 265, H681-H690.
Pelleg et al., "Mechanism of action of ATP on canine pulmonary vagal C fibre nerve terminals", J. Physiol., 1996, 490.1, 265-275.
Rankin et al., "Adenosine or adenosine triphosphate for supraventricular tachycardias? Comparative double-blind randomized study in patients with spontaneous or inducible arrhythmias", Am. Heart J., 1990, 119(2), 316-323.
Remington's Pharmaceutical Sciences, 18th Ed., Gennaro Alphonso (ed.), Mack Publishing Company, Easton, PA, 1990.
Rinne et al., "Comparative effects of adenosine triphosphate on accessory pathway and atrioventricular nodal conduction", Am. Heart J., 1988, 115(5), 1042-1047.
Rossi et al., "Modification par les nucleotides adenyliques de l'effet chronotrope de la stimulation du vague sur le coeur de rat", CR Soc. Biol., 1967, 161, 860-861.
Saito et al., "Intravenous Injection of Adenosine Triphosphate for Assessing Sinus Node Dysfunction in Patients with Sick Sinus Syndrome", Arzneim-Forsch/Drug Res., 1993, 43, 1313-1316.
Sharma et al., "Disparate Effects of Adenosine Triphosphate on Sinus Node Automaticity and AV Nodal Conduction in Man", JACC, 1987, 9, 246A.
Sharma et al., "Comparative Quantitative Electrophysiologic Effects of Adenosine Triphosphate on the Sinus Node and Atrioventricular Node", Am. J. Cardiol., 1988, 61, 330-335.
Sharma et al., "Intravenous Adenosine Triphosphate during Wide QRS Complex Tachycardia: Safety, Therapeutic Efficacy, and Diagnostic Utility", Am. J. Med., 1990, 88, 337-343.
Sharma et al., "Negative Chronotropic Effects of Adenosine Triphosphate on the Sinus Node are Mediated by Muscarinic Cholingeric and not Purinergic Receptors", JACC, 1988, 11(2), 227A.
Trezise et al., "Effects of divalent cations on the potency of ATP and related agonists in the rat isolated vagus nerve: implications for P.sub.2 purinoceptor classification", Br. J. Pharmacol., 1994, 113, 463-470.
Trezise et al., "Characterization of purinoceptors mediating depolarization of rat isolated vagus nerve", Br. J. Pharmacol., 1993, 110, 1055-1060.
Viskin et al., "Clinical and Electrophysiologic Effects of Magnesium Sulfate on Paroxysmal Supraventricular Tachycardia and Comparison with Adenosine Triphosphate", Am. J. Cardiol., 1992, 70, 879-885.
Viskin et al., "Acute management of paroxysmal atrioventricular junctional reentrant supraventricular tachycardia: Pharmacologic strategies", Am. Heart. J., 1990, 120, 180-188.
Wayne et al., "The Effect of Adenosine Triphosphate on the Electrocardiogram of Man and Animals", Br. Heart J., 1949, 11, 55-67.
Katchanov, et al., "Intracoronary ATP Triggers a Vagus Nerve Dependent Cardiac Depressor Reflex in the Canine Heart", Circulation 94: I-489 (Nov. 1, 1996).
Katchanov, et al., "Electrophysiological-anatomic correlates of ATP-triggered vagal reflex in the dog. III. Roles of cardiac afferents" Am. J. Physiol. 270 (Heart Circ. Physiol. 39); H1785-H1790 (1996).
Pelleg & Hurt, "Adenosine 5'-Triphosphate Induces Chemosensitive Pulmonary-Cardiac Depressor Reflex", Circulation 86:I-637, abstr #2534 (1992).
Allegheny University of the Health Sciences
Jarvis William R. A.
LandOfFree
Process for regulating vagal tone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for regulating vagal tone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for regulating vagal tone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-307057